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A three-part tandem mass spectrometric strategy that entails MSn analysis and a post-column
LC-MS cobalt complexation method is developed to identify flavonoid monoglucuronide
metabolites synthesized using the 1A1 isozyme of human UDP-glucuronosyltransferase
(UGT). Ten flavonoid aglycons were used as substrates, spanning the subclasses of flavones,
flavonols, and flavanones. The products were characterized by LC-MS and LC-MSn, with
post-column cobalt complexation employed to pinpoint the specific sites of conjugation. The
dissociation of complexes of the form [Co(II) (flavonoid glucuronide  H) (4,7-diphenyl-1,10-
phenanthroline)2]
 allowed identification of the products and differentiation of isomers. The
correlation between glycosylation site and elution order is used to provide additional
structural confirmation. Flavonoids lacking a 3= hydroxyl group were glucuronidated only at
position 7, while those containing this functionality also formed 3=-O-glucuronides and
sometimes 4=-O-glucuronides, thus supporting the conclusion that the presence or absence of
the 3=-OH group is the major determinant of the regioselectivity of glucuronidation. Moreover,
the specific distribution of multiple glucuronide products (7-O, 3=-O, 4=-O) is governed by the
subclass of flavonoid. (J Am Soc Mass Spectrom 2008, 19, 246–256) © 2008 American Society
for Mass SpectrometryMuch progress has been made in the under-standing of flavonoid metabolism over thepast decade. The currently accepted paradigm
involves the consumption of flavonoid glycosides in
plant-based food products, deglucosylation in the small
intestine by -glucosidase or lactose phloridzin hydro-
lase, and rapid metabolism by Phase I and (especially)
Phase II enzymes [1–3]. Glucuronidation and sulfation
are important metabolic routes for most flavonoids,
while methylation or hydroxylation may also occur
depending on the structure of the molecule in question
[2, 3]. There has also been a report of glutathione-
related metabolites in human urine [4]. As a result of
these rapid conjugation reactions, neither the original
flavonoid glycosides (except anthocyanins) nor the ag-
lycon forms (except catechins) are found in plasma
[5– 8]. Early reports of unmodified flavonoid glycosides
circulating in the bloodstream [9 –11] were likely mis-
taken identifications of flavonoid glucuronides, which
have similar chromatographic and ultraviolet (UV)
spectroscopic characteristics [7, 12]. Flavonoids that fail
to be absorbed in the small intestine may be broken
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doi:10.1016/j.jasms.2007.11.004down by microflora in the large intestine [1–3]. This
process may release the free aglycons, which can then
be absorbed and metabolized, but mostly results in the
release of small phenolic acids, which are expelled in
the urine [1–3]. Quantitative in vivo studies generally
show that only a small percentage of consumed fla-
vonoid glycosides is recovered in urine as conjugated
Phase II metabolites [13–15]. Walle et al. used 14C-
labeled quercetin to show that up to 81% of the admin-
istered dose ultimately is exhaled in the form of carbon
dioxide [16]. There remains considerable interest in the
conjugated metabolites as they may retain some of the
bioactivity of the original molecules [5, 17].
In spite of breakthroughs in the field of flavonoid
metabolism, much is still unknown about the precise
structure of Phase II flavonoid metabolites, particularly
in terms of the conjugation positions. Most reports do
not supply this information, identifying observed me-
tabolites imprecisely as, for example, unspecified quer-
cetin glucuronides. A recent review [5] listed all conju-
gated metabolites that have been identified in human in
vivo studies, but the very short list included conjugates
of only a few flavonoid aglycons. One reason for the
dearth of such information is a lack of sensitive and
specific analytical methods. While there are several
approaches currently available, there are problems as-
sociated with each. The standard method for structural
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resonance (NMR) spectroscopy, but its lack of sensitiv-
ity does not lend itself to analysis of low-concentration
metabolites, especially when scaling up is prohibitive
(such as in vivo bioavailability, pharmacokinetic, and
mechanistic studies). Thus, few metabolism studies
have employed this technique [18, 19]. An alternative
method using UV spectroscopy [20] to determine the
conjugation position of flavonoids has been used only
rarely for metabolites [17], probably due to the complex
set of experiments with numerous UV shift reagents
required to make this determination. A third strategy
requires synthesis of suspected metabolites and com-
parison of the chemical properties of these synthetic
compounds with those of the observed metabolites.
While this approach is sometimes employed to identify
flavonoid metabolites [13, 21, 22], it is too laborious for
routine use.
We have developed several methods for identifying
the conjugation positions and saccharide identities of
flavonoid glycosides using tandem mass spectrometry
[23–29]. These methods exploit the natural chelating
ability of flavonoids to form metal complexes in solu-
tion, which can then be analyzed in a mass spectrometer
for structural identification. Upon collision-induced
dissociation (CID), characteristic fragmentation pat-
terns are observed that allow the conjugation positions
to be determined. These fragmentation patterns are
consistent enough to provide positive identification of
unknown compounds without the need for standards.
For example, a manganese complexation method [26]
that distinguished five different glucosylation positions
as well as glucoside/galactoside isomers was used to
identify kaempferol 3-O-glucoside, kaempferol 3-O-gal-
actoside, isorhamnetin 3-O-glucoside and isorhamnetin
3-O-galactoside in a Silphium albiflorum extract [30].
Most recently, we reported a metal complexation/
tandem mass spectrometry method for differentiating
the conjugation positions of monoglucuronidated fla-
vonols, flavones, and flavanones [31]. The metal com-
plexation strategy entailed formation of complexes of
the type [Co(II) (FG  H) (4,7-dpphen)2]
 where (FG 
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Scheme 1. Structures of flavonoidH) is one molecule of deprotonated flavonoid glucuro-nide and (4,7-dpphen)2 are two molecules of an auxil-
iary ligand, 4,7-diphenyl-1,10-phenanthroline. Upon
CID, this complex yielded product ions corresponding
to the loss of a glucuronic acid moiety, of an auxiliary
ligand, and of the aglycon portion of the flavonoid, in
various combinations and ratios that correlated with the
position of glucuronidation. A four-way differentiation
of the 3-O-, 7-O-, 3=-O-, and 4=-O-glucuronides of quer-
cetin was demonstrated. This previous investigation
focused on a limited set of flavonoid glucuronides, but
we speculated that the versatility and sensitivity of the
method would allow facile adaptation to other fla-
vonoid metabolites, such as the ones produced enzy-
matically in the present study.
The purpose of the current work is two-fold. The first
goal is to explore the wider applicability of the de-
scribed metal complexation methods to flavonoid me-
tabolism studies. Second, we report the regiospecificity
of flavonoid glucuronidation by the 1A1 isozyme of
human UDP-glucuronosyltransferase (UGT1A1). While
there have been several studies on the glucuronidating
activity of various isozymes of UGT using flavonoids as
substrates [32–38], fewer have explored the regioselec-
tivity of such reactions [19, 39]. This report represents
the first comprehensive assessment of the impact of the
structural features of flavonoids on the enzymatic for-
mation of flavonoid glucuronides. The glucuronidated
derivatives of 10 flavonols, flavones, and flavanones
(structures of the flavonoid aglycons are shown in
Scheme 1) provide a diverse set of analytes to challenge
the performance of the new method. The correlation
between flavonoid conjugation sites and reversed-phase
high-performance liquid chromatography (HPLC) reten-
tion time is also discussed and used as an additional
tool in elucidating the structures of the enzymatically
synthesized products.
Experimental
Materials
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tin, myricetin, hesperetin, naringenin, and quercetin
were purchased from Sigma-Aldrich (St. Louis, MO).
Eriodictyol, kaempferol, luteolin, luteolin 7-O-glu-
coside, and luteolin 4=-O-glucoside were purchased
from Indofine (Hillsborough, NJ). Apigenin, homoerio-
dictyol, quercetin 3-O-glucoside, and quercetin 4=-O-
glucoside were purchased from Extrasynthèse (Genay,
France). Quercetin 7-O-glucoside was purchased from
Apin (Abingdon, UK). Quercetin 3-O-glucuronide,
quercetin 7-O-glucuronide, quercetin 3=-O-glucuronide,
and quercetin 4=-O-glucuronide were synthesized [22,
31] by Paul Needs and Paul Kroon at the Institute of
Food Research (Norwich, UK). Potassium phosphate
was purchased from Thermo Fisher Scientific, Inc.
(Waltham, MA).
Enzymatic Synthesis of Flavonoid Glucuronides
The method for synthesizing the flavonoid glucu-
ronides was adapted from one described by Plumb et al.
[40]. The UGT1A1, having an estimated enzyme con-
centration of 12 mg/mL, was divided into 25 L
aliquots, which were stored at 80 °C until use. Fla-
vonoids were prepared as 10 mM solutions in metha-
nol, which were employed despite turbidity of a few
solutions. Synthesis occurred in a microcentrifuge tube,
to which were added 2 mM aqueous UDPGA (65 L),
20 mM potassium phosphate buffer pH 7.0 (378.75 L),
and 10 mM flavonoid (6.25 L). The reaction was
initiated by adding a 25 L aliquot of UGT1A1 to the
tube. The tubes were incubated in a 37 °C water bath
(VWR Model 1227; West Chester, PA) with gentle
agitation for 6 h. A few reactions were repeated with 1 h
incubation times, but these gave similar results to the
6 h incubations, so these data will not be specifically
presented here. Reactions were stopped by adding 1.5
mL acetone. The tubes were centrifuged for 10 min at
16,000 g, and the supernatants were removed and
blown with nitrogen to evaporate the acetone. The
remaining supernatant was refrigerated until analysis.
LC-MSn Analysis
Liquid chromatography took place on aWaters Alliance
2695 HPLC system (Milford, MA). The stationary phase
was a Waters Symmetry C18 column, 2.1  50 mm, 3.5
m particle size, with a guard column. Typical injection
volumes were 15 to 30 L for negative ion mode
analyses, and 30 to 45 L for positive ion mode. The
mobile phases were 0.33% formic acid in water (A) and
0.33% formic acid in methanol (B). A typical gradient
began at 35% B, increased to 50% B over 25 min, then
increased to 95% B over 2 min, with a constant flow rate
of 0.1 mL/min. For the naringenin, eriodictyol, and
homoeriodictyol reaction products, the first part of the
gradient increased from 30% B to 45% B in 25 min;
while for acacetin the first part of the gradient increasedfrom 40% B to 55% B in 25 min. The column effluent
was sent directly to the mass spectrometer.
All mass spectrometry was performed on an LCQ
Duo (Thermo Electron, Waltham, MA) quadrupole ion
trap with electrospray ionization (ESI). Samples were
analyzed in both negative and positive ion modes. In
both polarities, a spray voltage of 5.0 kV was used, the
heated capillary temperature was 200 °C, and the auto-
matic gain control was set to a target of 2  107 ions
with a maximum injection time of 500 ms and five
microscan averaging. All other mass spectrometer pa-
rameters were set as needed to obtain optimal signal.
Negative ion mode was used to search for flavonoid
glucuronides and to confirm the identities of the agly-
con portion of these molecules. Positive ion mode was
used for analysis of metal complexes, which were
formed by post-column addition of a methanolic solu-
tion of 5 M CoBr2 and 4,7-dpphen. These reagents
were infused at a rate of 20 L/min controlled by a
syringe pump, and added to the column effluent via a
tee between the column and the mass spectrometer.
Due to the fragility of the metal complexes, an isolation
width of 4 Da was used [41]. Because varying the
collision energy will change the appearance of fragment
ion spectra, a constant normalized collision energy [42]
of 35% (of 5 Vp-p) was used to dissociate the complexes.
HPLC Retention Time Analysis
Retention time was used as a source of supplementary
data for the identification of the flavonoid glucuronides.
To determine trends in retention order, flavonoid gly-
cosides and glucuronides were injected individually,
and the retention times were measured by a Waters 486
UV detector. All other chromatographic equipment was
the same as used to analyze the enzymatic synthesis
products. The gradient employed began at 15% B,
increased to 70% B over 12 min, then increased to 95%
B over 2 min, with a flow rate of 0.3 mL/min. Unlike the
slow, specific gradients used to separate the reaction
products, this gradient allows the quick separation of a
wider variety of flavonoid derivatives.
Results and Discussion
For identification of the flavonoid glucuronides, the two
key steps include the determination of the aglycon
skeleton and the location of the site of conjugation. In
our approach, the aglycon skeleton is elucidated from
MSn spectra of the deprotonated flavonoid glucuronide
with spectral comparison to standard flavonoid agly-
cons. The site of conjugation is pinpointed based on
interpretation of the MS/MS spectra of metal com-
plexes of the type [Co(II) (FG  H) (4,7-dpphen)2]
. As
discussed in an earlier report [31], the characteristic
signs of 7-O-glucuronidation from this type of metal
complex include significant losses of the glucuronic
acid moiety (GlcA) and of the auxiliary ligand
(Aux), both individually and concurrently, as well as
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diagnostic fragment for the 7-O-glucuronidation posi-
tion. The metal complexes of B-ring-glucuronides typi-
cally display significant amounts of the Aux and
(Aux GlcA) fragment ions upon CID, but yield only
minor amounts of the GlcA fragment ion [31]. Upon
CID, metal complexes of flavonol 3-O-glucuronides
produce the (Aux  GlcA) fragment ion predomi-
nantly [31]. Supplemental Figure S1(which can be
found in the electronic version of this article) shows
proposed structures for these general types of product
ions.
Single-Product Reactions
After the enzymatic incubation of each of the 10 fla-
vonoids, the initial screening employed LC-MS with
negative ion mode analysis. The total ion chromato-
grams were searched for masses corresponding to the
aglycon (unreacted starting material), the monoglucu-
ronidated flavonoid (aglycon  176), and the diglucu-
ronidated flavonoid (aglycon  176  176). Unreacted
aglycon was observed in most cases, but no diglucu-
ronidated products were produced in any of the reac-
tions. All of the reactions produced monoglucu-
ronidated products, with five flavonoids generating a
single product, and the other five producing either two
or three products. This section concerns the former
group, consisting of apigenin, naringenin, acacetin,
kaempferol, and homoeriodictyol.
Although most studies involving the identification of
flavonoid conjugates by mass spectrometry do not
employ MSn for verification of the flavonoid skeleton,
we have recently encountered a urinary metabolite with
the correct mass and initial fragments for a quercetin
glucuronide sulfate, but which required MS4 analysis to
prove that it was not a quercetin derivative at all [43].
Hence, confirming the identity of the aglycon portion is
an important step in identifying these molecules and is
essential for preventing false positives. The MS/MS
spectra of each of the monoglucuronidated products
showed the characteristic loss of a glucuronic acid
residue, 176 Da. An additional isolation/dissociation
step (MS3) was used to fragment the aglycon portions of
these molecules. The resulting spectra are shown in
Figure 1. Because the flavonoid aglycons yield a variety
of product ions, the structures were easily confirmed by
comparing the MS/MS spectra of the aglycon stan-
dards, which were nearly identical to the spectra
shown. Acacetin, like many methoxylated flavonoid
aglycons, yields only a single fragment ion due to the
loss of a methyl radical, which is not a diagnostic
dissociation pathway [44, 45]. Hence, the MS4 spectrum
of the acacetin monoglucuronide is shown in Figure 1
rather than the MS3 spectrum, and it was compared
with the MS3 spectrum of the acacetin standard (be-
cause there is no glucuronic acid moiety to remove, one
less stage of fragmentation is required). Some of the
diagnostic dissociation routes include retro Diels-Alderpathways that lead to the 1,3A ion (m/z 151) and small
molecule losses such as H2O, CO, and CO2 [46,
47].
The metal complexation methods described in the
Experimental section were used to elucidate the loca-
tion of the glucuronic acid moiety of these monoglucu-
ronidated flavonoids. In particular, complexes of the
type [Co(II) (FGH) (4,7-dpphen)2]
 self-assembled in
the LC effluent (in which CoBr2 and 4,7-diphenyl-1,10-
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Figure 1. MSn spectra used to confirm the identities of the
aglycon skeletons of deprotonated flavonoid monoglucuronides.
(a) apigenin monoglucuronide, 445¡269¡ (b) naringenin mono-
glucuronide, 447¡271¡ (c) acacetin monoglucuronide, 459¡
283¡ 268¡ (d) kaempferol monoglucuronide, 461¡285¡ (e)
homoeriodictyol monoglucuronide, 477¡301¡.phenanthroline were introduced post-column), were
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tandem mass spectrometry. The CID mass spectra of
these complexes are shown in Figure 2. All five of the
complexes show evidence of glucuronidation at the 7
position, based on the diagnostic pathways summa-
rized above (e.g., Aux, GlcA, Agl), and thus all
products are identified as the 7-O-glucuronides of the
relevant flavonoid.
The fragmentation patterns also show some depen-
dence on the class of flavonoid in the complex. Com-
plexes involving flavanone (naringenin and homoerio-
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Figure 2. CID mass spectra of [Co(II) (FG-H) (4,7-dpphen)2]

complexes of flavonoid monoglucuronides. (a) FG  apigenin,
1168¡ (b) FG  naringenin, 1170¡ (c) FG  acacetin, 1182¡ (d)
FG  kaempferol, 1184¡ (e) FG  homoeriodictyol, 1200¡.dictyol) 7-O-glucuronides produce greater relativeabundances of the diagnostic ion due to loss of the
aglycon moiety (Agl), as well as those due to loss of a
glucuronic acid residue (GlcA) and loss of the auxil-
iary ligand in conjunction with the elimination of a
glucuronic acid residue (Aux  GlcA). Additionally,
they produce a significant fragment ion resulting from
the loss of both the auxiliary ligand and the aglycon
group, (Aux  Agl). The relative abundances of these
ions are lower for the complex involving the flavonol
(kaempferol) 7-O-glucuronide, and lowest for those
complexes involving flavone (apigenin and acacetin)
7-O-glucuronides. The analogous complex involving
baicalin (a flavone 7-O-glucuronide) was reported to
show similarly low abundances of these fragment ions
[31].
The remaining potential glucuronidation sites
should also be considered in case of ambiguous frag-
ment ion signatures from the metal complexes. The
Agl and GlcA ions do not feature prominently as
dissociation products of flavonoid B-ring-glucuronide
complexes, so the glucuronidation at the 3= and 4=
positions is ruled out. Flavonoid 5-O-conjugates are
purported to be unfavorable products due to hydrogen
bonding to the 4-keto group [3, 47]. Nonetheless, an
enzymatic synthesis of flavonoid 5-O-glucuronides has
been reported [48, 49]. Our work has suggested that the
fragmentation of metal complexes containing flavonoid
5-O-glucuronides mimics that of the 3-O-glucuronides
(unpublished data). None of the spectra in Figure 2
display the (Aux  GlcA) ion as the only abundant
fragment, so both the 3-O- and 5-O-glycosylation posi-
tions are ruled out, further corroborating the initial
identification of the five unknown compounds as 7-O-
glucuronides.
HPLC Retention Time Analysis
The enzymatic incubations of the other five flavonoids
(luteolin, eriodictyol, quercetin, hesperetin, and myrice-
tin) all produced more than one glucuronide derivative.
The presence of multiple products means that retention
time analysis can be used to assist in compound iden-
tification. Since this information plays a crucial role in
identifying some of the glucuronidated products, a
discussion of this approach is warranted before present-
ing the remaining mass spectral data.
There are several known trends regarding flavonoid
structure and reversed-phase HPLC retention times.
Since saccharides are more polar than flavonoid agly-
cons, flavonoid diglycosides elute before flavonoid
monoglycosides, which elute before flavonoid aglycons
[50]. It has also been reported that the retention time
order is flavanones  flavonols  flavones, for com-
pounds that otherwise have the same substitution pat-
terns [50]. Furthermore, studies have shown that the
identities of the saccharides influence HPLC mobility in
predictable ways. For example, when all else is equal, a
7-rutinoside elutes before a 7-neohesperidoside, and a
3-galactoside elutes before a 3-glucoside [50]. Such
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reversed-phase HPLC retention times, regardless of the
exact chromatographic method employed [30, 51–55].
We have observed that similar generalizations can be
made in cases in which both the flavonoid portion and
the glycosidic portion are the same, with only the
glycosylation site differing between compounds. Table
1 lists the retention times for three groups of such
isomers. In all three groups, the 7-O-glycoside elutes
before the 4=-O-glycoside. When the 3-O-glycoside is
included, it elutes between these two isomers. Finally,
quercetin 3=-O-glucuronide elutes after quercetin 4=-O-
glucuronide. Thus, the retention times of such isomers
can be ordered based on glycosylation site as 7  3  4=
 3=. This elution order for quercetin monoglucu-
ronides has been reported previously [12, 19, 56]. Re-
garding the rarer 5-O-glycosides, Grayer et al. reported
that the 5-O-glucosides of luteolin and apigenin elute
before their 7-O-glucoside analogs [57]. Harborne and
Boardley reported the retention time of quercetin 5-O-
glucoside as lower than that of quercetin 3-O-glucoside
[58]. We have also observed a case in which the 5-O-
glucuronide, the 7-O-glucuronide and the 3-O-glucuro-
nide of a flavonol eluted in that order (unpublished
results). The evidence points towards a general overall
elution order (by position of conjugation) of 5  7  3
 4=  3=, at least for flavonoid glucosides and
glucuronides.
The significance of deciphering this elution rule is
that it may be used to confirm the identities of flavonoid
glucosides or glucuronides that have been elucidated
by tandem mass spectrometric methods. Moreover, an
otherwise unidentifiable isomer may be assigned by
retention time if some of the other isomers have been
identified. Both strategies will be applied to the identi-
fication of compounds from reactions that yielded mul-
tiple products.
Multiproduct Reactions
The same LC-MS negative ion mode screening strategy
Table 1. HPLC retention times of selected isomeric flavonoid
glycosides
Aglycon Linkage Saccharidea
Retention time
(min)
Quercetin 7-O- Glc 8.19
Quercetin 3-O- Glc 9.04
Quercetin 4=-O- Glc 9.82
Luteolin 7-O- Glc 8.78
Luteolin 4=-O- Glc 10.09
Quercetin 7-O- GlcA 8.72
Quercetin 3-O- GlcA 9.28
Quercetin 4=-O- GlcA 10.46
Quercetin 3=-O- GlcA 11.32
aGlc: glucose, GlcA: glucuronic acid.described earlier was also pursued for the reactionproducts of luteolin, eriodictyol, quercetin, hesperetin,
and myricetin. Two or three different glucuronides
were identified in each elution profile based on the
diagnostic loss of a glucuronic acid moiety (176 Da) in
the CID mass spectra. Once identified as glucuronides,
these products were subjected to MS3 analysis to yield
the aglycon-specific fragmentation patterns shown in
Figure 3. The monoglucuronidated flavonoid isomers in
each reaction mixture yielded almost identical MS3
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Figure 3. MSn spectra used to confirm the identities of the
aglycon skeletons of deprotonated flavonoid monoglucuronides
(earliest eluting isomer from each mixture is shown). (a) luteolin
monoglucuronide, 461¡285¡ (b) eriodictyol monoglucuronide,
463¡287¡ (c) quercetin monoglucuronide, 477¡301¡ (d) hesp-
eretin monoglucuronide, 477¡301¡ (e) myricetin monoglucu-
ronide, 493¡317¡.
252 DAVIS AND BRODBELT J Am Soc Mass Spectrom 2008, 19, 246–256profiles, though only the results from the earliest-
eluting isomer are shown. All of these spectra matched
the MS/MS spectra obtained from standards of the
flavonoid aglycons.
After confirming that the reaction products were
monoglucuronides and identifying the aglycon struc-
tures, CID of the [Co(II) (FG-H) (4,7-dpphen)2]
 com-
plexes was used to identify the glucuronidation posi-
tions in a manner similar to that described above. The
MS/MS fragmentation patterns of the earliest-eluting
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Figure 4. CID mass spectra of [Co(II) (FG-H) (4,7-dpphen)2]

complexes of earliest eluting flavonoid monoglucuronides from
multi-product reactions. (a) FG  luteolin, 1184¡ (b) FG 
eriodictyol, 1186¡ (c) FG quercetin, 1200¡ (d) FG hesperetin,
1200¡ (e) FG  myricetin, 1216¡.isomer from each mixture are shown in Figure 4, andthe characteristic array of fragments indicate 7-O-glu-
curonidation in each case. The flavanone (eriodictyol
and hesperetin) 7-O-glucuronide complexes again yield
the highest abundance of the Agl and several other
fragment ions, while the flavone (luteolin) 7-O-glucuro-
nide complex shows the lowest abundances of these
fragment ions. The relative yield of 7-O-glucuronides
was very low in the quercetin and myricetin reaction
mixtures based on the intensities of these components
in the chromatographic profiles, and 75 L injections
were required to obtain good mass spectra. The low
signal intensity of myricetin 7-O-glucuronide resulted
in a very noisy MS/MS spectrum from the complex,
especially in the high mass range. The diagnostic Agl
fragment ion is indistinguishable from the noise. The
identification can still be made on the basis of three
fragment ions: Aux, GlcA and –(Aux  GlcA).
Typically, only metal complexes of 7-O-glucuronides
yield high abundances of all three of these ions, though
flavonoid class also affects the abundances.
The enzymatic reactions involving eriodictyol and
hesperetin yielded only one product in addition to the
7-O-glucuronide, while the remaining flavonoids pro-
duced two additional products. All of these products
eluted after the respective 7-O-glucuronides. The CID
mass spectra from the metal complexes of the latest-
eluting isomers in each mixture are shown in Figure 5.
These fragmentation patterns are indicative of B-ring-
glucuronidation. As stated earlier, the two characteristic
fragmentation pathways of complexes containing B-
ring-glucuronides are Aux and (Aux  GlcA). The
fragment ion abundances from these B-ring-glucuro-
nide metal complexes appear to be partially dependent
on the class of the flavonoid, as noted earlier for the
7-O-glucuronide complexes. While all of the spectra
show both of the characteristic fragment ions of B-ring-
glucuronides, the metal complex of the flavone (luteo-
lin) B-ring-glucuronide strongly favors the loss of the
auxiliary ligand, while the complexes of the flavanone
(eriodictyol and hesperetin) B-ring-glucuronides prefer-
entially yield the (Aux  GlcA) ion. The flavonol
(quercetin and myricetin) B-ring-glucuronide com-
plexes display intermediate behavior, yielding similar
amounts of each of these two fragment ions. Hence,
knowledge of the flavonoid class helps in the interpre-
tation of the fragmentation patterns of these metal
complexes.
Some of the spectra also contain small amounts of
the GlcA fragment ion, which is usually associated
with 7-O-glucuronidation. For the hesperetin gluc-
uronide data in Figure 5d, this is likely a contribution
from the earlier-eluting hesperetin 7-O-glucuronide,
as the two compounds were only partially separated.
However, the -GlcA fragment ion appears to be an
intrinsic part of the spectrum for the complexes of the
quercetin and myricetin B-ring-glucuronides because
there are no co-eluting isomers in these cases. A
reasonable guideline is that the MS/MS of flavone
7-O-glucuronide complexes displays at least 15%
253J Am Soc Mass Spectrom 2008, 19, 246–256 REGIOSELECTIVITY OF UGT1A1 TOWARD FLAVONOIDSrelative abundance of the  GlcA fragment ion (Fig-
ure 2a and c; Figure 4a), but this fragment ion is
absent from the MS/MS of flavone B-ring-glucuro-
nide complexes (Figure 5a). For flavonols, the same
product ion appears with 50% relative abundance
for the 7-O-glucuronides (Figure 2d, Figure 4c and e),
but with 10% relative abundance for B-ring-glucu-
ronides (Figure 5c and e). Since product ion distribu-
tions are dependent on collision energy [31], these
guidelines are only applicable to the conditions used
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Figure 5. CID mass spectra of [Co(II) (FG-H) (4,7-dpphen)2]

complexes of latest eluting flavonoid monoglucuronides from
multi-product reactions. (a) FG  luteolin, 1184¡ b) FG 
eriodictyol, 1186¡ (c) FG quercetin, 1200¡ (d) FG hesperetin,
1200¡ e) FG  myricetin, 1216¡.in this set of experiments.The collision energy used in the current set of
experiments was specifically chosen to take advantage
of a subtle difference in the fragmentation of the com-
plexes of quercetin 4=-O-glucuronide and quercetin
3=-O-glucuronide [31]. When a collision voltage in the
range of 1.5 to 1.8 V was used [31], it was noted that a
greater abundance of the Aux fragment ion relative to
the (Aux  GlcA) fragment ion, as occurs in Figure 5c,
is indicative of quercetin 3=-O-glucuronide. If the rela-
tive abundances are reversed, this is characteristic of
quercetin 4=-O-glucuronide; and this was observed for
an isomeric compound in the quercetin reaction mix-
ture that eluted just before quercetin 3=-O-glucuronide
(data not shown). The retention time guidelines also
support the identification of these two products as
quercetin 4=-O-glucuronide and quercetin 3=-O-glucuro-
nide, in order of elution.
There are no known rules for differentiating the
3=-O- and 4=-O-glucuronides of flavonoids other than
quercetin. Hence, other means are required to precisely
identify the remaining B-ring-glucuronides. The hesp-
eretin B-ring-glucuronide is easiest to assign. Hespere-
tin has only one B ring hydroxyl group, so the unknown
compound must be hesperetin 3=-O-glucuronide. Like
quercetin, both the luteolin and myricetin reaction
mixtures also display two glucuronide species that
elute after the 7-O-glucuronide. As luteolin has two B
ring hydroxyl groups, the two unknowns are assigned
as luteolin 4=-O-glucuronide and luteolin 3=-O-glucuro-
nide, in order of elution. These assignments were pos-
sible despite the failure of luteolin 4=-O-glucuronide to
form significant amounts of the metal complex in ques-
tion, for reasons that remain unknown. Both late-elut-
ing myricetin glucuronides form complexes, which dis-
sociate to provide the same two major fragment ions
shown in Figure 5e. Myricetin has three B ring hydroxyl
groups but two are equivalent, so the two isomers are
identified as myricetin 4=-O-glucuronide and myricetin
3=-O-glucuronide, in order of elution. The eriodictyol
derivative is the most difficult to assign because there
are two B ring hydroxyl groups but only one B-ring-
glucuronide is formed. While it is impossible to pre-
cisely identify this compound based on the available
data, it is hypothesized to be eriodictyol 3=-O-glucuro-
nide, not eriodictyol 4=-O-glucuronide, for reasons that
will be explained in the next section.
An estimate of the relative product yields of these
multi-product reactions was made based on the peak
areas of the initial negative ion mode MS scans from the
chromatographic profiles (Table 2). Some of our results
can be compared with data presented by Boersma et al.
[19], who reported product distributions for reactions of
luteolin and quercetin with UGT1A1 based on HPLC,
LC-MS and NMR spectroscopy. Their observed product
distribution was 21:29:50 for the 7-O-, 3=-O- and 4=-O-
glucuronides of luteolin, which is similar to our results
(10:30:60). The distribution for quercetin was 6:85:9,
which also parallels our data (trace:90:10). As in the
254 DAVIS AND BRODBELT J Am Soc Mass Spectrom 2008, 19, 246–256current study, quercetin 3-O-glucuronide was not ob-
served as a reaction product.
Structure–Activity Relationships
The flavonoids that produce a single monoglucu-
ronidated product and those which produce multiple
products constitute two distinct groups, distinguished
by the presence or the absence of a 3= hydroxyl group.
The sole reaction product for compounds that lack this
structural feature is the 7-O-glucuronide. The regio-
selectivity of UGT1A1 shifts toward the flavonoid B
ring when a 3= hydroxyl group is present, but the extent
to which this happens depends on other structural
features of the flavonoid. The two flavanones with a 3=
hydroxyl group, eriodictyol and hesperetin, form only
one product in addition to the 7-O-glucuronide. The
additional product of hesperetin was identified as the
3=-O-glucuronide, but the additional product of eriod-
ictyol could not be conclusively determined. However,
the important activating properties of the 3= hydroxyl
group suggest that eriodictyol 3=-O-glucuronide is the
product that is formed. For both eriodictyol and hesp-
eretin, there remains a significant yield of the 7-O-
glucuronide (relative yields of 40% and 70%, respec-
tively). Luteolin is the only flavone in the study that
features a 3= hydroxyl group. There is a larger shift
toward B-ring-glucuronidation as luteolin 7-O-glucuro-
nide accounts for only about 10% of the product. For the
flavonols containing the 3= hydroxyl group (quercetin
and myricetin), only trace amounts of their 7-O-glucu-
ronides were formed. Hence, while the presence or
absence of the 3= hydroxyl group is the major determi-
nant of the regioselectivity of glucuronidation, there are
secondary effects due to flavonoid class.
The structural features that govern the regioselectiv-
ity of the glucuronidation reaction (the presence or
absence of the 3= hydroxyl group, the C2–C3 double
bond, and the 3 hydroxyl group) are also important
factors in the antioxidant capability of flavonoids, and
may act synergistically in that capacity as well [59]. The
same structural features have also been cited as impor-
tant determinants of the antiproliferative effects of
flavonoids against several cancer cell lines [60]. It is
interesting to note that while the presence of the ortho-
catechol group (i.e., the 3= and 4= hydroxyl groups) is
Table 2. Estimated product distributions from multi-product
reactions
Aglycon % 7-O-GlcA % 3=-O-GlcA % 4=-O-GlcA
Eriodictyol 40 60a —
Hesperetin 70 30 —
Luteolin 10 30 60
Quercetin Trace 90 10
Myricetin Trace 70 30
All values were rounded to the nearest 10%.
aThe compound may possibly be eriodictyol 4=-O-glucuronide.often claimed to be a source of beneficial flavonoidactivity, our work shows a tendency for this group to be
preferentially metabolized by UGT1A1, which would
potentially mitigate the bioactivity of these molecules.
On the other hand, the B-ring-glucuronides of quercetin
retain the inhibitory effects of the aglycon against
xanthine oxidase and lipoxygenase better than when
quercetin is conjugated at other positions [17].
Conclusions
A three-part tandem mass spectrometry strategy that
entails MS/MS analysis of deprotonated metabolites to
pinpoint those that are glucuronides, then MS3 analysis
to elucidate the specific aglycon structure, then MS/MS
analysis of metal complexes of the type [Co(II) (FG-H)
(4,7-dpphen)2]
 allows confident identification of enzy-
matically-synthesized flavonoid glucuronides, includ-
ing the conjugation site. This strategy was used to
determine the regioselectivity of UGT1A1 toward fla-
vonol, flavone, and flavanone substrates. The 7 position
of the flavonoid is the sole site of glucuronidation
except when a 3= hydroxyl group is present. A 3=
hydroxyl group promotes the formation of B-ring-
glucuronides in addition to 7-O-glucuronides. The fla-
vonoid class determines the product distribution in
such cases. This result represents a significant advance
in understanding flavonoid metabolism. Studies involv-
ing other UGT isozymes are planned. Furthermore, we
have demonstrated the success of metal complexation
methods in the identification of new flavonoid mono-
glucuruonides with the assistance of HPLC retention
time analysis. Of the 18 flavonoid monoglucuronides
produced, only one remains ambiguous (the eriodictyol
B-ring-glucuronide). Insights regarding the effect of fla-
vonoid class on the fragmentation of the metal complexes
will prove useful for future applications of this method.
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